MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd Expansion Plans Announcement 2024 - Diabetes Reversal Initiative Madhavbaug conducted a Glucose Tolerance Test event across 350+ clinics, testing over 1,153 type 2 diabetes patients, showcasing the potential for diabetes reversal. This event, streamed live, sets a new benchmark in diabetes care, doubling the previous record from 2018..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Vaidya Sane Ayurved Laboratories Ltd